B cell involvement in the pathogenesis of ankylosing spondylitis

R Wilbrink, A Spoorenberg, GMPJ Verstappen… - International journal of …, 2021 - mdpi.com
Extensive research into ankylosing spondylitis (AS) has suggested the major role of
genetics, immune reactions, and the joint–gut axis in its etiology, although an ultimate …

Il-23 inhibition in ankylosing spondylitis: where did it go wrong?

D Baeten, IE Adamopoulos - Frontiers in immunology, 2021 - frontiersin.org
Axial spondyloarthritis is a prevalent form of chronic arthritis which is related to psoriatic
arthritis and skin psoriasis. TNF and IL-17A as well as IL-17F are key cytokines contributing …

CXCL12/CXCR4-Rac1–mediated migration of osteogenic precursor cells contributes to pathological new bone formation in ankylosing spondylitis

H Cui, Z Li, S Chen, X Li, D Chen, J Wang, Z Li… - Science …, 2022 - science.org
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by inflammatory
back pain and spinal ankylosis due to pathological new bone formation. Here, we identified …

Piezo1-mediated mechanotransduction promotes entheseal pathological new bone formation in ankylosing spondylitis

S Chen, Z Li, D Chen, H Cui, J Wang, Z Li… - Annals of the …, 2023 - ard.bmj.com
Objective The aim of this study was to identify the role of Piezo1-mediated
mechanotransduction in entheseal pathological new bone formation and to explore the …

CD27-CD38lowCD21low B-Cells Are Increased in Axial Spondyloarthritis

R Wilbrink, A Spoorenberg, S Arends… - Frontiers in …, 2021 - frontiersin.org
B-cells have received little attention in axial spondyloarthritis (axSpA) and for this reason
their role in pathogenesis remains unclear. However, there are indications that B-cells may …

[HTML][HTML] Dual blockade of TNF and IL-17A inhibits inflammation and structural damage in a rat model of spondyloarthritis

I Hammoura, RH Fiechter, SH Bryant… - International journal of …, 2022 - mdpi.com
The tumor necrosis factor (TNF) and IL-23/IL-17 axes are the main therapeutic targets in
spondyloarthritis. Despite the clinical efficacy of blocking either pathway, monotherapy does …

The gut-enthesis axis and the pathogenesis of Spondyloarthritis

D Mauro, A Nakamura, N Haroon, F Ciccia - Seminars in immunology, 2021 - Elsevier
Subclinical inflammation is associated with Spondylarthritis (SpA). SpA patients show
features of dysbiosis, altered gut barrier function, and local expansion of innate and innate …

[HTML][HTML] Updates on ankylosing spondylitis: pathogenesis and therapeutic agents

SH Kim, SH Lee - Journal of rheumatic diseases, 2023 - synapse.koreamed.org
Ankylosing spondylitis (AS) is an autoinflammatory disease that manifests with the unique
feature of enthesitis. Gut microbiota, HLA-B* 27, and biomechanical stress mutually …

Lessons on SpA pathogenesis from animal models

M Breban, S Glatigny, B Cherqaoui… - Seminars in …, 2021 - Springer
Understanding the complex mechanisms underlying a disorder such as spondyloarthritis
(SpA) may benefit from studying animal models. Several suitable models have been …

The role of the IL-23/IL-17 axis in disease initiation in spondyloarthritis: lessons learned from animal models

M Mandour, S Chen, MGH van de Sande - Frontiers in immunology, 2021 - frontiersin.org
Spondyloarthritis (SpA) is a spectrum of chronic inflammatory joint diseases that frequently
presents with inflammation of the axial skeleton, peripheral joints, entheses, skin, and gut …